Table 4.
Meta-analysis results of adverse events
| Outcome | Meta-analysis | Heterogeneity | Certainty | ||
|---|---|---|---|---|---|
| Risk ratio (95% CI) | p-value | τ 2 | Prediction interval | ||
| Abdominal pain | 2.93 (1.13–7.6) | 0.027 | 0 | 1.13–7.60 | High |
| Constipation | 3.23 (1.14–9.18) | 0.028 | 0.38 | 0.65–16.03 | Moderate |
| Diarrhoea | 1.5 (0.69–3.24) | 0.308 | 0.14 | 0.52–4.34 | Low |
| Nausea | 1.44 (0.87–2.39) | 0.152 | 0.08 | 0.69–3.02 | Low |
| Serious adverse event | 0.81 (0.52–1.26) | 0.345 | 0 | 0.52–1.26 | Low |
| Vomiting | 2.57 (1.39–4.77) | 0.003 | 0 | 1.39–4.77 | High |